Table 1.
Study design and baseline characteristics within included studies for systematic review.
| Reference | Publication year | Country | Study interval | Publication type | Study design | Number of patients | Age (years)a | Gender (% male) | Diagnosis | Liver involved |
|---|---|---|---|---|---|---|---|---|---|---|
| Bower and Little | 2013 | Australia | 2002–2012 | Abstract | Retrospective cohort | 23 | 62.5 | 48 | ICC | 10–70% |
| Camacho et al. | 2013 | USA | NA | Abstract | Prospective cohort | 21 | NA | NA | ICC | NA |
| Camacho et al. | 2013 | USA | NA | Abstract | Prospective cohort | 9 | 58 | 56 | ICC | NA |
| Chaiteerakij et al. | 2011 | USA | 2000–2009 | Abstract | Retrospective cohort | 20 | NA | NA | ICC | NA |
| Hoffmann et al. | 2012 | Germany | 2007–2010 | Full manuscript | Prospective cohort | 33 | 65.2 | 54.5 | ICC + mets | <50% |
| Hyder et al. | 2013 | USA | 1992–2012 | Full manuscript | Retrospective cohort | 46 | NA | 48 | ICC + mets | Tumour >5 cm |
| Martinez et al. | 2013 | NA | 2012 | Abstract | Prospective cohort | 2 | NA | NA | ICC | NA |
| Mouli et al. | 2013 | USA | 2003–2011 | Full manuscript | Prospective cohort | 46 | 68 | 54 | ICC + mets | <25% |
| Prajapati et al. | 2012 | USA | 2002–2012 | Abstract | Prospective cohort | 24 | NA | NA | ICC | NA |
| Saxena et al. | 2010 | Australia | 2004–2009 | Full manuscript | Prospective cohort | 25 | 57 | 52 | ICC + mets | <50% |
| Shridhar et al. | 2012 | USA | 2009–2011 | Abstract | Retrospective cohort | 40 | NA | NA | ICC + mets | NA |
| Turkmen et al. | 2013 | Turkey | 2008–2012 | Full manuscript | Retrospective cohort | 9 | NA | NA | ICC + mets | <70% |
NA. not available; ICC. intrahepatic cholangiocarcinoma; mets. metastatic disease present.
a
Mean.